baber/WOPTO huggingface dataset:
Patent NZ-330968-A (NZ)
Title: Preserving the colouration of cut apples using solution containing cysteine, calcium chloride or calciaum lactate, an osmolite and a metal ion chelator
Inventor: GAWAD KAMELYA I
IPC: A23B7/157
Filed: 1998-07-13
Abstract: Disclosed is a method and a solution for retarding the discolouration of freshly cut apple pieces. The apple is cut and exposed to an aqueous solution comprising antioxidant selected from the group of L-cystine, D-cystine and D.L-cystine in a weight percent concentration of from about 0.1 to about 0.4 percent of the solution, a calcium source selected from calcium chloride and calcium lactate in a weight percent concentration of from about 0.1 to about 1.0 percent of the solution, and an osmolite selected from alcohol sugars that are not metabolised by bacteria in a weight percent of from about 0.2 to about 1.0 percent of the solution, and the remainder is water.
Patent NZ-332671-A (NZ)
Title: Wood preservatives containing a quaternary ammonium compound
Inventor: LICHTENBERG FLORIAN
IPC: B27K3/36
Filed: 1997-05-22
Abstract: A wood preservative having biocidal properties comprising at least one quaternary ammonium compound of formula R4-N+(R1)(R2)-R3  A-  is claimed wherein: R1 is a C8-18 alkyl group or an optionally substituted benzyl group; R2 is a C8-18 alkyl group; R3 is a C1-4 alkyl group or a group of the formula -[CH2-CH2-O]n-H; R4 is a C1-4 alkyl group; n is a number from 0.5 to 8 and A is the anion of an organic carboxylic acid which contains 2 to 12 C atoms and carries at least one hydroxyl, amino or sulphonic acid group. Also claimed is a quaternary ammonium compound of the formula as depicted above wherein R1, R2 and R4 are as defined above; A is aminoacetate (glycinate), 2-amino- or 3-amino propionate (a- or b- alaninate) or o-, m- or p-hydroxybenzoate and R3 is C1-4 alkyl group.
Patent NZ-335843-A (NZ)
Title: Reinforced plastic container
Inventor: BERGLUND KURT
IPC: B29C53/60
Filed: 1997-11-03
Abstract: PCT No. PCT/SE97/01832 Sec. 371 Date May 24, 1999 Sec. 102(e) Date May 24, 1999 PCT Filed Nov. 3, 1997 PCT Pub. No. WO98/20274 PCT Pub. Date May 14, 1998Glass fiber reinforced plastic container for liquefied petroleum gas or compressed air. The container is made of two halves, the open ends of which are conically chamfered and joined to each other by an adhesive. In each half the reinforcement is made with inner, intermediate and outer layers, which comprise longitudinally as well as transversely and diagonally oriented bundles of reinforcing strands.
Patent NZ-502704-A (NZ)
Title: Naphthyridinones and pharmaceuticals thereof and their use in inhibiting cellular proliferation and protein tyrosine kinase or cell cycle kinase enzymatic activity
Inventor: BARVIAN MARK ROBERT
IPC: A61K31/4375
Filed: 1998-08-13
Abstract: A compound of formula I, wherein: ---is absent or a bond, R1 is selected from the formulae shown below formula I R2 is alkyl, cycloalkyl or bicycloalkyl, R5 is H, halogen, aryl, substituted aryl, heteroaryl, or substituted heteroaryl, and the pharmaceutically acceptable salts thereof. A pharmaceutical composition comprising the compound of formula I is also described. The compounds of formula I are useful for treating cancer; or for treating or preventing atherosclerosis, restenosis, or psoriasis. The compounds of formula I are useful for inhibiting protein tyrosine kinases and cell cycle kinases.
Patent NZ-505300-A (NZ)
Title: Matrix granule comprising a protein matrix of a protein, a structuring agent and a sugar or a sugar alcohol
Inventor: BECKER NATHANIEL T
IPC: C12N9/98
Filed: 1998-12-18
Abstract: A granule comprises a seed particle, a protein core comprising a protein matrix comprising a protein such as an enzyme or hormone mixed together with a combination of a sugar or sugar alcohol and a structuring agent and an outer barrier or coating. The structuring agent can be a polysaccharide and a polypeptide such as starch, modified starch, cellulose, modified cellulose, carrageenan, gum arabic, acacia gum, xanthan gum, locust bean gum, guar gum, chitosan, gelatin, casein, collagen, polyaspartic acid or polyglutamic acid. The sugar can be glucose, fructose, raffinose, maltose, lactose, trehalose or sucrose.
Patent NZ-505933-A (NZ)
Title: Incorporation of cholesterol lowering agents into confectionery dosage forms
Inventor: BUEHLER GAIL K
IPC: A23L1/30
Filed: 2000-07-24
Abstract: An orally administrable composition comprising; A candy comprising an effective amount of a cholesterol-lowering agent to reduce serum cholesterol in a human, wherein the cholesterol-lowering agent replaces at least a portion of the fat content of the candy without adversely affecting the organoleptic properties of the composition.
Patent NZ-506677-A (NZ)
Title: Method and device for recording real-time information
Inventor: VAN NIEUWENHOVEN MARCEL S E
IPC: G11B27/32
Filed: 1999-12-21
Abstract: In a method of recording real-time information on an information carrier, e.g. audio on an optical disc, the real-time information is compressed to units comprising a variable amount of compressed data, and playback parameters are determined in dependence of the compressed data. The playback parameters comprise an access list (Main_Acc_List) having entries, each subsequent entry being assigned to a subsequent interval of a fixed playback time and comprising a pointer (Entry[N]) to a unit within said interval. In a player the real-time information may be accessed at a selected point of playing time. The corresponding entry in the access list is determined by dividing the selected time by the interval. The entry provides the pointer (Entry[N]) to the unit corresponding to the selected playing time. Interpolation may be used for calculating an address at a selected playing time within an interval, and the accuracy may be improved by a margin parameter (Access_Flags[N]), which indicates the maximum distance between the unit of the selected playing time and the interpolated address.
Patent NZ-511739-A (NZ)
Title: New esters derived from substituted phenyl-cyclohexyl compounds
Inventor: DEL CASTILLO NIETO JUAN CARLOS
IPC: C07C233/11
Filed: 1999-11-04
Abstract: A compound of general formula (I), wherein; R1 is A, B or C; R2 is OH; R3 is H, or R2 and R3 together form a double bond; R4 is H or alkyl; R5 is H, NH2 , NH-R11 or O-R11; R6 is H, CO-R11, O-R11 or halogen; R7 is H, alkyl, O-alkenyl or phenyl, or R6 and R7 together is -CH=CR12-CR13=CH-, forming an optionally substituted condensed aromatic ring; R8 is OH, -O-CO-N(CH3)2 or NH-R11; R9 and R10 are H or alkyl or together form a -CH2- CH2- bond; R11 is phenyl or phenyl optionally substituted by 1 or more of the following: halogen, NO2, alkyl, alkenyl, OH, or NH2; R12 and R13 are H, or O-alkyl; and its salts and optical isomers. The compounds are useful in the treatment of pain.
Patent NZ-511988-A (NZ)
Title: Ostomy or incontinence pouch with capsule(s) and having stoma shield to prevent spurting of released agent(s)
Inventor: STEER GRAHAM E
IPC: A61F5/44
Filed: 1999-12-22
Abstract: The ostomy or incontinence pouch has stoma aperture 18, and at least one capsule 24 which contains an agent for affecting the pouch contents in use, and a shield 44 over stoma aperture 18 to obstruct spurting of the agent through aperture 18 when released from the capsule.
Patent NZ-512411-A (NZ)
Title: Cluster pre-lift for milking parlor with lifting and lowering device to raise and lower cluster above and below platform receiving cows
Inventor: EPPERS PAUL A
IPC: A01J5/017
Filed: 2001-06-15
Abstract: A milking parlor has a platform receiving cows and having a plurality of spaced stall dividers defining milking stalls therebetween, each stall divider having a milking cluster including a claw and teat cups. A cluster drop and lift retractor, provided by a detacher cylinder, raises the cluster to an up position above the platform ready for attachment of the teat cups to the teats of a cow in a respective stall, and lowers the cluster to a down position below the platform after detachment of the teat cups from the teats of the cow. A cluster pre-lift control and sequence actuates the retractor to raise the cluster to the up position prior to milking such that when the dairyman operator is ready to milk the cow, the milking cluster is already in the up ready for attachment operator having to bend down to lift the milking cluster from the down position.
Patent NZ-518194-A (NZ)
Title: Toothbrush having a bristle pattern providing enhanced cleaning
Inventor: HOHLBEIN DOUGLAS J
IPC: A46B9/04
Filed: 2000-10-06
Abstract: A toothbrush having a plurality of peripheral bristle tufts and a plurality of adjacent bristle bars located internally within the head thereto, which bristle bars provide support for the peripheral bristle tufts during brushing, such that the stiffness and associated cleaning ability of the peripheral bristle tufts is enhanced
Patent NZ-525992-A (NZ)
Title: Centrifugal combustion method using air-flow in a furnace
Inventor: KIM JIWON
IPC: F23G5/00
Filed: 2001-08-11
Abstract: A centrifugal and divided space combustion method requires the installation of a cylindrical fuel pot, a first combustion chamber, a second combustion chamber and an exhaust pot. Also required are the installation of upper and the lower pots outside the first combustion chamber and the fuel pot in order to have the lower and the upper air paths inside the outer pots. One or several ventilator(s) to provide air-flow is/are tangentially connected to the upper and the lower air paths at the lower part of the upper outer pot. Preferably, several air-flow control devices are located at the upper part of the upper air path. Complete combustion only with the air supply into the furnace is thereby provided, the space in the furnace being divided into many combustive sectors by the air-flow.
Patent NZ-526322-A (NZ)
Title: Immunomodulatory polynucleotides and methods of using the same
Inventor: FEARON KAREN L
IPC: C12N15/00
Filed: 2001-12-27
Abstract: The composition of an immunomodulatory polynucleotide is described which comprises an immunostimulatory sequence with the formula: 5Æ-X1X2AX3CGX4TCG-3Æ (SEQ ID NO:62) wherein X1 is T, G, C or Z; Z is 5-bromocytosine; X2 is T, G, A or U; X3 is T, A or C; X4 is T, G or U; and wherein the sequence is not 5Æ-TGAACGTTCG-3Æ (SEQ ID NO:63) or 5Æ-GGAACGTTCG-3Æ. The use of the composition is also described such as in the manufacture of a medicament for treating infectious diseases and increasing interferon levels.
Patent NZ-527959-A (NZ)
Title: A flow meter
Inventor: BOND DEREK F
IPC: G01F23/26
Filed: 2003-09-03
Abstract: A flow meter comprising an inflow chamber having a first fluid inlet, an outflow chamber housed in the inflow chamber and having a second fluid inlet, which is in fluid communication with the inflow chamber, and a fluid outlet by which fluid can drain from the outflow chamber, and a sensing device having an elongate sensor which is positioned, or adjacent to and downstream of , the second fluid inlet, the second fluid inlet being of limited dimensions so that, in use, a head of fluid is formed in the inflow chamber and the flow rate of the fluid passing through the second fluid inlet is monitored based on the extent of the elongate sensor which is covered by the fluid.
Patent NZ-530835-A (NZ)
Title: Early-warning system comprising sodar for wind energy turbines
Inventor: WOBBEN ALOYS
IPC: F03D17/00
Filed: 2002-06-26
Abstract: Wind energy turbines are relatively expensive capital goods, in terms of size and output design, which need to be protected against destructive forces, damage or other causes of a malfunction of a wind energy turbine, if the promised long service life of the wind energy turbine is to be obtained. At the same time, it is always desirable to operate wind energy turbines with the maximum possible output in order to achieve the highest possible energy yield. Both objectives, (i.e. a long service life and the highest possible energy yield) are in part diametrically opposed. In principle it would be possible to operate a wind energy turbine partly in an overload range to increase the energy yield; this would however simultaneously lead to a significant shortening of the service life. If, on the other hand, a wind energy turbine is operated in very low wind speed ranges, the turbine has better protection than others, but its energy yield is insufficient. The aim of the invention is to provide measures and options for protecting a wind energy turbine against damage or other causes of a malfunction of a wind energy turbine, whilst at the same time achieving the maximum possible energy yield. The invention also relates to a wind energy turbine comprising a SODAR system, which is mounted on the nacelle of the wind energy turbine and which captures data from the area in front of the rotor of the wind energy turbine.
Patent NZ-535759-A (NZ)
Title: Anti-collision interrogation pulse focusing system for use with multiple surface acoustic wave identification tags and method of operation thereof
Inventor: HARTMANN CLINTON S
IPC: G06K7/00
Filed: 2003-03-19
Abstract: A system and method for limiting code collisions from multiple SAW identification tags is disclosed. The system includes: a means for focusing an interrogation pulse to within a defined space, and a means for discriminating between coded responses returned from tags located within the defined space.
Patent NZ-539439-A (NZ)
Title: Frustoconical plant protector with reinforced bottom end to assist in ground insertion
Inventor: YEALANDS PETER WAYNE MAURICE
Filed: 2005-04-13
Abstract: A frustoconical plant protector 1 has reinforced bottom end 7 to assist in ground penetration.
Patent NZ-542709-A (NZ)
Title: Directly operated pneumatic valve having a differential assist return
Inventor: NEFF ROBERT H
Filed: 2005-09-28
Abstract: A fluid control valve includes a valve body having both fluid inlet and discharge ports. A flow passage axially extending within the valve body communicates with the inlet and discharge ports. A valve member within the flow passage is movable by an actuator force in a first direction to direct a pressurised fluid from the inlet to the discharge port. The valve member includes first and second valve heads having different diameters and a valve seating member. The valve seating member engages first and second sealing diameters of the flow passage, the second sealing diameter being smaller than the first. Fluid pressure acting on the different diameters of the first valve head and valve seating member in contact with the second sealing diameter creates a net return force directing the valve member in a second direction opposite to the first direction upon removal of the actuator force.
Patent NZ-543762-A (NZ)
Title: Use of an alpha2delta subunit calcium channel modulator such as gabapentin or pregabalin in a medicament for treating non-painful disorders of the bladder
Inventor: THOR KARL BRUCE
Filed: 2003-12-19
Abstract: Use of a GABA analog that is an alpha2delta subunit calcium channel modulator in the manufacture of a medicament for treating urinary frequency, urinary urgency, nocturia, OAB dry or detrusor instability.
Patent NZ-544257-A (NZ)
Title: Variable volume resuscitator
Inventor: STEVENSON GARY NOEL
Filed: 2005-12-19
Abstract: A resuscitator (1) wherein the air chamber (11) is formed from at least three nestable sections (16a-16f) that are adapted to slide telescopically relative to each other along the longitudinal axis to pump air from the air chamber (11) through an outlet (18).
Patent NZ-547194-A (NZ)
Title: Process for converting heterocyclic ketones to amido-substituted heterocycles that are used as intermediates in the synthesis of cannabinoid (CB-1) antagonists
Inventor: BRANDT THOMAS ANDREW
IPC: C07D205/04
Filed: 2004-11-22
Abstract: Disclosed is a safe and convenient process for preparing amido-substituted heterocyclic compounds of formula (I) from the corresponding heterocyclic ketone, wherein the process comprises the steps of: (1) reacting a compound having a formula R4d-NH-R4d' and a cyanide source with a compound of formula (la) to form an intermediate of formula (lb); (2) hydrolyzing the nitrile group of the compound of formula (Ib) with alkaline hydrogen peroxide in the presence of dimethylsulfoxide to form a compound of formula (Ic); (3) removing the amino-protecting group to form the compound of formula(I) ; and (4) optionally forming a pharmaceutically acceptable salt of said compound of formula(I), wherein the variables are as defined in the specification.
Patent NZ-547362-A (NZ)
Title: N-Arylhydrazine derivatives for seed treatment
Inventor: VON DEYN WOLFGANG
IPC: A01N37/52
Filed: 2004-12-02
Abstract: Method for the protection of seeds from soil pests is disclosed, which comprises contacting the seeds before sowing and/ or after pregermination with a compound of formula (I): wherein W is chlorine or trifluoromethyl; X and Y are each independently chlorine or bromine; R1 is alkyl, alkenyl, alkynyl, or cycloalkyl which may be substituted with 1 to 3 halogen atoms, or alkyl which is substituted by alkoxy; R2 and R3 are alkyl or may be taken together to form cycloalkyl which may be unsubstituted or substituted by 1 to 3 halogen atoms; R4 is hydrogen or alkyl, or the enantiomers or salts thereof, in pesticidally effective amounts.
Patent NZ-548330-A (NZ)
Title: Porous materials and method of production thereof
Inventor: COOPER ANDREW IAN
IPC: C08J9/16
Filed: 2005-01-28
Abstract: Check later Disclosed are water dispersible or water soluble porous bodies comprising a three dimensional oil and water emulsion-templated open-cell lattice containing 10 to 95 % by weight of a polymeric material which is soluble in water, and, less than 5 % by weight of a surfactant, a hydrophobic material incorporated into the lattice to be dispersed when the water soluble polymer dissolves, said porous bodies having an intrusion volume as measured by mercury porosimetry (as hereinafter described) of at least about 3 ml/g, and, with the proviso that said porous bodies are not spherical beads having an average bead diameter of 0.2 to 5mm. And a method for making the same comprising the steps of: providing an intimate mixture of the polymeric material and any surfactant in a liquid medium: providing a fluid freezing medium at a temperature effective for rapidly freezing the liquid medium; cooling the liquid medium with the fluid freezing medium at a temperature below the freezing point of the liquid medium for a period effective to rapidly freeze the liquid medium; and freeze-drying the frozen liquid medium to form the porous bodies by removal of the liquid medium by sublimation.
Patent NZ-552046-A (NZ)
Title: Index and method of use of adapted food compositions for dysphagic persons
Inventor: DUFRESNE THERESE
IPC: A23L5/30
Filed: 2005-06-01
Abstract: Disclosed is a method for preparing a solid food that has improved transit from lips to stomach in a dysphagic person comprising modulating Swallowing Texture (ST) index of a solid food composition by adjusting at least one parameter selected from the group consisting of firmness, adhesiveness, springiness and cohesiveness in order to obtain a ST index below 80, said ST index being calculated according to the formula: ST index = (F + IAI) x S x C wherein F is firmness, IAI is absolute value of adhesiveness, S is springiness and C is cohesiveness, whereby a ST index below 80 is considered safe to swallow for a dysphagic person. The disclosure also relates a method in which a quantitative and descriptive approach is used to adapt the food texture in the clinical management of dysphagia. The disclosure further relates to a method of use for determining and modulating the physical characteristics of foods in a manner to allow the food composition at serving temperature to have a desired combination of firmness, adhesiveness, springiness and cohesiveness to overcome dysphagia-related problems.
Patent NZ-553260-A (NZ)
Title: Composition comprising protein material and non-oxidizable fatty acid entities
Inventor: BERGE ROLF
IPC: A23L33/00
Filed: 2005-07-19
Abstract: Disclosed is the use of a preparation comprising a combination of a fermented and/or hydrolyzed protein material and one or more compounds comprising a non beta-oxidizable fatty acid entity represented by (a) the general formula R"-COO-(CH2)2n+1-X-R', wherein X is a sulphur atom, a selenium atom, an oxygen atom, a SO group or a SO2 group; n is an integer of 0 to 11; and R' is an alkyl group, saturated or unsaturated and R" is a hydrogen atom or an alkyl group, and/or (b) the general formula (I), wherein R1, R2, and R3 are as defined in the specification (c) the general formula (II), wherein A1, A2 and A3 are as defined in the specification andlor a salt or complex of the compounds according to (a)-(c) for the preparation of a pharmaceutical or nutritional composition for the prevention andlor treatment of insulin resistance, obesity, diabetes, fatty liver, hypercholesterolemia, dyslipidemia, atherosclerosis, coronary heart disease, thrombosis, stenosis, secondary stenosis, myocardial infarction, stroke, elevated blood pressure, endothelial dysfunction, procoagulant state, polycystic ovary syndrome, the metabolic syndrome, cancer, an inflammatory disorder, and a proliferate skin disorder. Also disclosed is the use of the above combination for the preparation of a composition for improving the total body lipid composition of an animal, the composition, a method for producing an animal based product comprising feeding the composition, a method of improving the total body lipid composition of animal comprising feeding the composition and a method of treating an agricultural animal comprising administering the composition.
Patent NZ-555683-A (NZ)
Title: Oxadiazole derivatives as dgat inhibitors
Inventor: BIRCH ALAN MARTIN
IPC: A61K31/4245
Filed: 2005-12-09
Abstract: Disclosed is an oxadiazole compound of formula (I) or a pharmaceutically-acceptable salt thereof, wherein Y is a direct bond, R2 and R1 are optionally substituted phenyl as disclosed within the specification. Also disclosed is a process of making a compound of formula (1) and the use of a compound of formula (I) in the manufacture of a medicament for use in the production of an inhibition of DGAT1 activity or the treatment of diabetes mellitus and/or obesity.
Patent NZ-561215-A (NZ)
Title: Small molecule inhibitors of MDM2 and uses thereof
Inventor: WANG SHAOMENG
IPC: A61K31/407
Filed: 2006-02-22
Abstract: Disclosed is a spirocyclic compound of formula I, or a salt or prodrug thereof, wherein X is CH, N, O, or S, and R8 is absent if need be, Y is O, S, or NR', and the other substituents are as defined in the specification. Also disclosed is a method of synthesising the compound. Also disclosed is the use of the compound to inhibit interatction between p53 or p53-related proteins and MDM2 or MDM2-related proteins, and to inhibit growth of a hyperproliferative cell containing p53 or p53-related proteins, and to protect normal cells from the toxic side effects of chemotherapeutic agents or treatments, such as in treating cancer.
Patent NZ-562635-A (NZ)
Title: Acoustical canopy system from non-self supporting panels adhered together to form self-supporting acoustical curved panel
Inventor: SPRINGER BRIAN L
IPC: E04B1/84
Filed: 2006-04-04
Abstract: An interior building system which includes a curved, acoustical, self-supporting composite panel which differentiates and accents the interior building space, and, at the same time, provides substantial sound absorbing capabilities. The composite panel is composed of two or more layers of non self-supporting soft fiber material and a discontinuous layer of adhesive interposed between each of the soft fiber layers. The system further includes mounting hardware for attaching the panel to the building structure. The mounting hardware has a perforated plate which is embedded in the panel which minimizes the visibility of the hardware, and, at the same time, provides enhanced load bearing capabilities.